drugset / Trial / NCT05932888
Safety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the study is to evaluate the safety and tolerability of single ascending (SAD) doses of QLM3003 compared to placebo. Also, pharmacokinetics (PK) of qlm3003 will be evaluated.
Timeline
- Start
- 2023-06-25
- Primary completion
- 2023-08-05
- Completion
- 2023-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | QLM3003 | Unknown | 1 % | — |
| Subject | QLM3003 | Unknown | 1.5 % | — |
| Subject | QLM3003 | Unknown | 2 % | — |